Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Autism Spectrum Disorder

3,4-dihydroxyphenylacetic acid has been researched along with Autism Spectrum Disorder in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yardimci, A1
Ertugrul, NU1
Ozgen, A1
Ozbeg, G1
Ozdede, MR1
Ercan, EC1
Canpolat, S1
Ohmura, Y1
Ichikawa, I1
Kumagaya, S1
Kuniyoshi, Y1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Autism Spectrum Disorder

ArticleYear
Effects of chronic irisin treatment on brain monoamine levels in the hypothalamic and subcortical nuclei of adult male and female rats: An HPLC-ECD study.
    Neuroscience letters, 2023, 05-29, Volume: 806

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autism Spectrum Disorder; Brain; Chromatography, High Press

2023
Stapedial reflex threshold predicts individual loudness tolerance for people with autistic spectrum disorders.
    Experimental brain research, 2019, Volume: 237, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Adaptation, Physiological; Adult; Analysis of

2019